P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate (Q44729076)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q19283882)
(Q71792160)
(P304) 401-408
(P407) (Q1860)
(P433) 3
(P478) 18
(P577) Monday, March 1, 2004
(P921) (Q29496)
(Q177094)
(P1433) (Q6534498)
(P1476) "P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate" (language: en)
(P2093) Illmer T
Schaich M
Freiberg-Richter J
Oelschlägel U
von Bonin M
Pursche S
Bergemann T
Schleyer E
(P2860) (Q34929139)
(Q27627097)
(Q29547900)
(Q33336718)
(Q29618788)
(Q45712588)
(Q44373949)
(Q34075619)
(Q44189518)
(Q28208049)
(Q38342389)
(Q43806484)
(Q34175760)
(Q40659027)
(Q44189751)
(Q44267685)
(Q40667580)
(Q34422183)
(Q44251759)
(Q78176526)
other details
description scientific article

External Links